SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-17-028422
Filing Date
2017-05-18
Accepted
2017-05-18 16:33:41
Documents
2
Group Members
AHMED SHAYAN FAZLUR RAHMAN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 11 v467376_sc13da11.htm SC 13D/A 69039
2 EXHIBIT 99.1 v467376_ex99-1.htm EX-99.1 3360
  Complete submission text file 0001144204-17-028422.txt   74151
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Subject) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45279 | Film No.: 17855276
SIC: 2834 Pharmaceutical Preparations

Mailing Address SHARJAH AIRPORT INTERNATIONAL FREE ZONE EXECUTIVE SUITE, P.O. BOX 9366 SHARJAH C0 00000
Business Address SHARJAH AIRPORT INTERNATIONAL FREE ZONE EXECUTIVE SUITE, P.O. BOX 9366 SHARJAH C0 00000 971-4-363-846
Eses Holdings (FZE) (Filed by) CIK: 0001506117 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C0 | Fiscal Year End: 0430
Type: SC 13D/A